CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-11-28 | HILZINGER KURT J Director | Other acquisition | +11,633 | 11,633 | ||
| 2016-11-28 | HILZINGER KURT J Director | Other acquisition · Warrant (Right to Buy) | +12,036 | 12,036 | ||
| 2016-11-28 | Canute Scott A Director | Other acquisition | +57,408 | 246,342 | ||
| 2016-11-28 | Canute Scott A Director | Other acquisition · Warrant (Right to Buy) | +37,315 | 37,315 | ||
| 2016-11-23 | Griffith Donald J. Director | Sale | −1 | $3.75 | $4 | 144,926 |
| 2016-11-11 | Gangloff Scott A. SVP, Development & Mfrg | Sale | −37,369 | $3.75 | $140K | 78,573 |
| 2016-11-11 | MCANDREW STEPHEN J SVP Bus. Strat. & Dev. | Sale | −21,367 | $3.75 | $80K | 36,604 |
| 2016-11-09 | Gangloff Scott A. SVP, Development & Mfrg | Conversion | −115,942 | 0 | ||
| 2016-11-09 | Gangloff Scott A. SVP, Development & Mfrg | Exercise or conversion | +115,942 | 115,942 | ||
| 2016-11-09 | Griffith Donald J. Director | Conversion | −144,927 | 0 | ||
| 2016-11-09 | Griffith Donald J. Director | Exercise or conversion | +144,927 | 144,927 | ||
| 2016-11-09 | MCANDREW STEPHEN J SVP Bus. Strat. & Dev. | Conversion | −57,971 | 0 | ||
| 2016-11-09 | MCANDREW STEPHEN J SVP Bus. Strat. & Dev. | Exercise or conversion | +57,971 | 57,971 | ||
| 2016-11-09 | Canute Scott A Director | Conversion | −57,971 | 0 | ||
| 2016-11-09 | Canute Scott A Director | Exercise or conversion | +57,971 | 188,934 | ||
| 2016-11-09 | Brady Todd C Director | Conversion | −28,985 | 28,985 | ||
| 2016-11-09 | Brady Todd C Director | Exercise or conversion | +28,985 | 153,288 | ||
| 2016-05-18 | Mohan Pankaj President & CEO | Conversion · Series A Preferred Stock | −106 | 0 | ||
| 2016-05-18 | Canute Scott A Director | Conversion | +58,500 | 130,963 | ||
| 2016-05-18 | Canute Scott A Director | Conversion · Series A Preferred Stock | −351 | 0 |
Page 19 of 20 · 386 trades